{"url_path":"/sec/bcyc/8-k/2026-05-21/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1761612/0001104659-26-065231-index.html","accession_number":"0001104659-26-065231","cik":"0001761612","ticker":"BCYC","issuer_name":"BICYCLE THERAPEUTICS PLC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1761612/0001104659-26-065231-index.html","primary_entity_key":"0001761612","primary_entity_name":"BICYCLE THERAPEUTICS PLC"},"word_count":77,"has_tables":true,"body_markdown":"**Item 9.01**\n**Financial Statements and Exhibits**\n\n \n\n(d)       Exhibits\n\n \n\n**Exhibit No.**\n \n**Description**\n\n[99.1](tm2615187d1_ex99-1.htm)\n \n[Press Release issued May 21, 2026](tm2615187d1_ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (formatted in Inline XBRL)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements\nof the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto\nduly authorized.\n\n \n\nDate: May 21, 2026\nBICYCLE THERAPEUTICS PLC\n\n \n \n\n \nBy:\n/s/\nTravis Thompson \n\n \nName:\nTravis Thompson \n\n \nTitle:\nChief Financial Officer"}